Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-26-001775

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 11.42M sh
Shares Diluted Q1 2026 · Mar 31, 2026 11.38M sh
Shares Diluted Q1 2026 · Mar 31, 2025 44.34M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$552.11K
Operating Cash Flow Q1 2026 · Dec 31, 2025 $172.18K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $328.31K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.15M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $661.93K
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.68M
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.48M
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.26M
Stockholders Equity Q1 2026 · Dec 31, 2024 $835.24K
Total Liabilities Q1 2026 · Mar 31, 2026 $645.75K
Total Liabilities Q1 2026 · Dec 31, 2025 $229.85K
Current Assets Q1 2026 · Mar 31, 2026 $2.19M
Current Assets Q1 2026 · Dec 31, 2025 $1.56M
Total Assets Q1 2026 · Mar 31, 2026 $2.33M
Total Assets Q1 2026 · Dec 31, 2025 $1.71M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 $0.01
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 $0.01
Sga Expense Q1 2026 · Mar 31, 2026 $625.81K
Sga Expense Q1 2026 · Mar 31, 2025 $433.56K
Rd Expense Q1 2026 · Mar 31, 2026 $49.72K
Rd Expense Q1 2026 · Dec 31, 2025 $37.54K
Net Income Q1 2026 · Mar 31, 2026 −$229.91K
Net Income Q1 2026 · Dec 31, 2025 $642.09K
Net Income Q1 2026 · Mar 31, 2025 $426.8K
Operating Income Q1 2026 · Mar 31, 2026 −$229.91K
Operating Income Q1 2026 · Mar 31, 2025 $426.8K
Gross Profit Q1 2026 · Mar 31, 2026 $485.6K
Gross Profit Q1 2026 · Mar 31, 2025 $896.15K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $265.35K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $330.93K
Revenue Q1 2026 · Mar 31, 2026 $750.95K
Revenue Q1 2026 · Mar 31, 2025 $1.23M